Discover
CLDX
Celldex Therapeutics, Inc.
39.63
1 x 33.03
1 x 44.67
bid
ask
+
0.51
1.30%
1 @ 04:00 PM
39.63 +0.00 (0.00%)
| Ytd | 45.91% | |
| 1y | 79.48% |
38.74
day range
39.84
21.77
52 week range
45.14
| Open | 38.86 | Prev Close | 39.12 | Low | 38.74 | High | 39.84 | Mkt Cap | 3.11B |
| Vol | 696.91K | Avg Vol | 1.03M | EPS | -4.35 | P/E | N/A | Forward P/E | -9.52 |
| Beta | 0.84 | Short Ratio | 7.85 | Inst. Own | 110.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-09 | 50-d Avg | 38.54 | 200-d Avg | 31.27 | 1yr Est | 58.07 |
CLDX News
benzinga.com
Morgan Stanley Maintains Overweight on Celldex Therapeutics, Raises Price Target to $46
Morgan Stanley analyst Judah Frommer maintains Celldex Therapeutics (NASDAQ:CLDX) with a Overweig
benzinga.com
Barclays Maintains Overweight on Celldex Therapeutics, Raises Price Target to $53
Barclays analyst Etzer Darout maintains Celldex Therapeutics (NASDAQ:CLDX) with a Overweight and
benzinga.com
Celldex Therapeutics Q2 EPS $(0.94) Beats $(1.07) Estimate, Sales $22.000K Miss $954.444K Estimate
Celldex Therapeutics (NASDAQ:CLDX) reported quarterly losses of $(0.94) per share which beat the ana